✦ LIBER ✦

PCN72 ECONOMIC EVALUATION OF SUNITINIB VS. INTERFERON-A AND BEVACIZUMAB + INTERFERON-A IN THE TREATMENT OF METASTATIC RENAL CELL CARCINOMA (CCRM) – BRAZILIAN PRIVATE HEALTH SYSTEM PERSPECTIVE

✍ Scribed by V Teich; CM Hashizume; T Marinho; C Charbonneau; A Naves

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCN32 ECONOMIC EVALUATION OF SUNITINIB,

✍ D Greenberg 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 87 KB

PCN29 ECONOMIC EVALUATION OF SUNITINIB F

✍ U Munir; Á Benedict; B Borgman; R Sandin; U Harmenberg; A Ullén; P Sandström 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 78 KB

4514 POSTER Economic evaluation of sunit

✍ Negrier, S.; Remák, E.; Brown, R.; Kim, S.T.; Charbonneau, C.; Motzer, R.J. 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 61 KB

PCN13 A COMPARATIVE EFFECTIVENESS ASSESS

✍ GH Mickisch; B Schwander; B Escudier; J Bellmunt; P Maroto; C Porta; S Walzer; U 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB

PCN40 COST ANALYSIS OF MANAGING ADVERSE

✍ CI Silva; I Monteiro; B Schwander 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 76 KB

Costs of managing adverse events in the

✍ Mickisch, G; Gore, M; Escudier, B; Procopio, G; Walzer, S; Nuijten, M 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 356 KB